| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.051 | 0.4 |